Should lipid-lowering agents be prescribed in the case of myasthenia

被引：0
|
作者：
Windler, E
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1996年 / 121卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Lipid-Lowering Agents
    Ewang-Emukowhate, Mfon
    Wierzbicki, Anthony S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (05) : 401 - 411
  • [2] MECHANISMS OF LIPID-LOWERING AGENTS
    SIRTORI, CR
    MANZONI, C
    LOVATI, MR
    CARDIOLOGY, 1991, 78 (03) : 226 - 235
  • [3] Lipid-Lowering Agents and Hepatotoxicity
    Demyen, Michael
    Alkhalloufi, Kawtar
    Pyrsopoulos, Nikolaos T.
    CLINICS IN LIVER DISEASE, 2013, 17 (04) : 699 - +
  • [4] PRESCRIBING LIPID-LOWERING AGENTS
    WHEATLEY, G
    BRITISH JOURNAL OF GENERAL PRACTICE, 1995, 45 (395): : 329 - 329
  • [5] Discontinuing lipid-lowering agents
    Davis, George F.
    JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (03) : 619 - 619
  • [6] New lipid-lowering Agents
    Sinning, David
    Landmesser, Ulf
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (02) : 92 - 101
  • [7] Lipid-lowering agents and myopathy
    Wortmann, RL
    CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (06) : 643 - 647
  • [8] A case for lipid-lowering?
    Durrington, P
    DIABETIC MEDICINE, 2000, 17 : 4 - 5
  • [9] Lipid-lowering agents, hypothyroidism and rhabdomyolysis
    Iglesias, GP
    Sanjuán, JAG
    González, CG
    Sánchez, PS
    REVISTA CLINICA ESPANOLA, 2000, 200 (04): : 236 - 237
  • [10] Lipid-lowering agents for nephrotic syndrome
    Kong, Xiangyu
    Yuan, Hao
    Fan, Junming
    Li, Zi
    Wu, Taixiang
    Jiang, Lanhui
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
12345